Severe neurological manifestations of covid-19: case series

Autores/as

  • Anna Carolina de Almeida Sufen Universidade do Oeste Paulista - UNOESTE
  • Helton Otsuka Universidade do Oeste Paulista - UNOESTE
  • Estefânia Costa Ribeiro Universidade do Oeste Paulista - UNOESTE
  • Maria Teresa Fernandes Castilho Garcia Universidade do Oeste Paulista - UNOESTE

Palabras clave:

COVID-19, neurologic manifestations, venous thrombosis, Guillain-Barre syndrome, encephalitis

Resumen

SARS-CoV-2 is the etiologic agent of the pandemic started in December 2019 and has been reaching alarming numbers worldwide. Neurological manifestations have been reported and must be highlighted. This study reports cases of severe neurological manifestations associated with COVID-19 in patients admitted to a tertiary hospital. The first patient was referred with history of generalized seizures after the diagnosis of COVID-19; imaging exam indicated cerebral venous thrombosis. The second patient, already treated for COVID-19, developed pain in the dorsal region, progressing to ascending paresthesia, and had diagnosis of Guillain-Barré Syndrome, with fatal outcome. The third patient, also with fatal outcome, presented with headache and left hemiparesis. After imaging exams, was discharged, but days after, returned with mental confusion and the hypothesis of encephalitis was confirmed. SARS-CoV-2 infection was confirmed after death. The main objective of this study is to report severe neurological manifestations related to COVID-19.

Descargas

Los datos de descarga aún no están disponibles.

Referencias

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017–1032. DOI: https://dx.doi.org/10.1038/s41591-020-0968-3

WHO COVID-19 Dashboard [Internet]. Geneva: World Health Organization; c2020 [cited 2022 Feb 6]. Available from: https://covid19.who.int/

Rahman HS, Aziz MS, Hussein RH, Othman HH, Salih Omer SH, Khalid ES, et al. The transmission modes and sources of COVID-19: A systematic review. Int J Surg Open. 2020;26:125–36. DOI: https://dx.doi.org/10.1016/j.ijso.2020.08.017

Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol. 2021;350. DOI: https://dx.doi.org/10.1016/j.jneuroim.2020.577436

Abboud H, Abboud FZ, Kharbouch H, Arkha Y, el Abbadi N, el Ouahabi A. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg. 2020;140:49–53. DOI: https://dx.doi.org/10.1016/j.wneu.2020.05.193

Pascarella G, Strumia A, Piliego C, Bruno F, del Buono R, Costa F, et al. COVID‐19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206. DOI: https://dx.doi.org/10.1111/joim.13091

Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767–83. DOI: https://dx.doi.org/10.1016/S1474-4422(20)30221-0

Frontera J, Mainali S, Fink EL, Robertson CL, Schober M, Ziai W, et al. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale. Neurocrit Care. 2020;33(1):25–34. DOI: https://dx.doi.org/10.1007/s12028-020-00995-3

Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218(3). DOI: https://dx.doi.org/10.1084/jem.20202135

Chen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, et al. A systematic review of neurological symptoms and complications of COVID-19. J Neurol. 2021;268:392–402. DOI: https://dx.doi.org/10.1007/s00415-020-10067-3

Meppiel E, Peiffer-Smadja N, Maury A, Delorme C, Landré S, Petitgars P, et al. Manifestations neurologiques associées à l’infection SARS-CoV-2: le registre français NeuroCOVID. Med Mal Infect. 2020;50(6):S20–1. DOI: https://dx.doi.org/10.1016/j.medmal.2020.06.047

Matschke J, Lütgehetmann M, Hagel C, Sperhake JP, Schröder AS, Edler C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919–29. DOI: https://dx.doi.org/10.1016/S1474-4422(20)30308-2

Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875–82. DOI: https://dx.doi.org/10.1016/S2215-0366(20)30287-X

Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, et al. Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infect. 2021;27(3):458–66. DOI: https://dx.doi.org/10.1016/j.cmi.2020.11.005

Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol. 2021;177:51–64. DOI: https://dx.doi.org/10.1016/j.neurol.2020.10.001

Hughes C, Nichols T, Pike M, Subbe C, Elghenzai S. Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19. Eur J Intern Med. 2020;7(5). DOI: https://dx.doi.org/10.12890/2020_001691

Cavalcanti DD, Raz E, Shapiro M, Dehkharghani S, Yaghi S, Lillemoe K, et al. Cerebral Venous Thrombosis Associated with COVID-19. AJNR Am J Neuroradiol. 2020;41(8):1370–6. DOI: https://dx.doi.org/10.3174/ajnr.A6644

Medicherla CB, Pauley RA, de Havenon A, Yaghi S, Ishida K, Torres JL. Cerebral Venous Sinus Thrombosis in the COVID-19 Pandemic. J Neuroophthalmol. 2020;40(4):457–62. DOI: https://dx.doi.org/10.1097/WNO.0000000000001122

Kow CS, Zaihan AF, Hasan SS. Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. J Stroke Cerebrovasc Dis. 2020;29(12). DOI: https://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105222

Tu TM, Goh C, Tan YK, Leow AS, Pang YZ, Chien J, et al. Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review. J Stroke Cerebrovasc Dis. 2020;29(12). DOI: https://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2020.105379

Valiuddin H, Skwirsk B, Paz-Arabo P. Acute transverse myelitis associated with SARS-CoV-2: A Case-Report. Brain Behav Immun. 2020;5. DOI: https://dx.doi.org/10.1016/j.bbih.2020.100091

Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019. JAMA Neurol. 2020;77(8). DOI: https://dx.doi.org/10.1001/jamaneurol.2020.2065

Gittermann LMT, Feris SNV, Giacoman AvO. Relación entre COVID-19 y síndrome de Guillain-Barré en adultos. Revisión sistemática. Neurologia. 2020;35(9):646–54. DOI: https://dx.doi.org/10.1016/j.nrl.2020.07.004

Munhoz RP, Pedroso JL, Nascimento FA, Almeida SM de, Barsottini OGP, Cardoso FEC, et al. Neurological complications in patients with SARS-CoV-2 infection: a systematic review. Arq Neuropsiquiatr. 2020;78(5):290–300. DOI: https://dx.doi.org/10.1590/0004-282x20200051

Arnaud S, Budowski C, Ng Wing Tin S, Degos B. Post SARS-CoV-2 Guillain-Barré syndrome. Clin Neurophysiol. 2020;131(7):1652–4. DOI: https://dx.doi.org/10.1016/j.clinph.2020.05.003

Oliveira VFL de, Ferreira E de NM. Complicações Neurológicas oriundas da infecção por SARS-CoV-2: uma revisão da literatura. Rev Neurociênc. 2020;28:1–14. DOI: https://dx.doi.org/10.34024/rnc.2020.v28.10789

Abildúa MJA, Atienza S, Monteiro GC, Aguirre MEE, Aguayo LI, Álvarez EF, et al. Encefalopatías y encefalitis durante la infección aguda por SARS-CoV2. Registro de la Sociedad Española de Neurología SEN COVID-19. Neurologia. 2021;36(2):127–34. DOI: https://dx.doi.org/10.1016/j.nrl.2020.11.013

Tandon M, Kataria S, Patel J, Mehta TR, Daimee M, Patel V, et al. A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19. Int J Infect Dis. 2021;104:390–7. DOI: https://dx.doi.org/10.1016/j.ijid.2021.01.002

Espíndola OM, Brandão CO, Gomes YCP, Siqueira M, Soares CN, Lima MASD, et al. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development. Int J Infect Dis. 2021;102:155–62. DOI: https://dx.doi.org/10.1016/j.ijid.2020.10.044

Freire-Álvarez E, Guillén L, Lambert K, Baidez A, García-Quesada M, Andreo M, et al. COVID-19-associated encephalitis successfully treated with combination therapy. Clin Infect Pract. 2020;7–8. DOI: https://dx.doi.org/10.1016/j.clinpr.2020.100053

Hassan M, Syed F, Rajput HM, Mushtaq HF, Khan NU, Badshah M. SARS-CoV-2 infection with pneumonia and encephalitis. Brain Hemorrhages. 2021;2(3):134–6. DOI: https://dx.doi.org/10.1016/j.hest.2021.02.002

Cleret de Langavant L, Petit A, Nguyen QTR, Gendre T, Abdelhedi J, Djellaoui A, et al. Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series. Rev Neurol. 2021;177(3):275–82. DOI: https://dx.doi.org/10.1016/j.neurol.2021.01.004

Publicado

2023-02-14

Cómo citar

Severe neurological manifestations of covid-19: case series . (2023). Colloquium Vitae. ISSN: 1984-6436, 14(1), 91-100. https://journal.unoeste.br/index.php/cv/article/view/4352

Artículos similares

1-10 de 25

También puede Iniciar una búsqueda de similitud avanzada para este artículo.